A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and testing for inherited genetic mutations linked with increased cancer risk.

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Metformin, a widely prescribed medication for type 2 diabetes, may help protect individuals from the 2 most common types of ...

Panelists discuss how the decision to treat vs observe alopecia areata (AA) depends on factors such as disease severity, ...

Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.

FD&C Red No. 3, a synthetic dye that imparts a bright cherry-red color, has primarily been used in food products such as ...

Patients with spinal muscular atrophy (SMA) type 2 showed improved motor ability when treated with intrathecal onasemnogene ...

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was ...

The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and ...

In part 2 of our interview with Karen Winkfield, MD, PhD, she speaks to the importance of ensuring health care accessibility ...

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...

The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more ...